FGF19 and metabolic syndrome: In addition, we also listed several novel identified modulatory biomarkers which play an important role in the regulation of dyslipidemia induced by hypothyroidism, including PCSK9, ANGPTL3, ANGPTL8, FGF-21, FGF-19, and several microRNAs.